TherapeuticsMD To Present At The Cowen And Company 34th Annual Health Care Conference
TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company
("TherapeuticsMD" or the "Company"), announced today that it will
present at the Cowen and Company 34
th Annual Health Care
TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company ("TherapeuticsMD" or the "Company"), announced today that it will present at the Cowen and Company 34 th Annual Health Care Conference taking place at the Boston Marriott Copley Place on March 3-5, 2014. Robert Finizio, Chief Executive Officer and Co-founder of TherapeuticsMD, will present on Wednesday, March 5, 2014 at 10:40am EST. The presentation will include material information on the Company, its operations, strategies and prospects. To hear the live presentation by audio webcast, visit the Company's website at www.therapeuticsmd.com at Events and Presentations on the Investors tab. An audio replay will be available for on-demand listening for thirty days after the presentation. About TherapeuticsMD, Inc. TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We are developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. We also manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD ® and BocaGreenMD ® brands. More information is available at the following websites: www.therapeuticsmd.com,www.vitamedmd.com,www.vitamedmdrx.com, and www.bocagreenmd.com.